{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:55:18Z","timestamp":1791449718359,"version":"4.3.3"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Anesth Analg Crit Care"],"DOI":"10.1186\/s44158-026-00459-8","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:03:53Z","timestamp":1790391833000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phenotype-based appropriateness of IGM-enriched polyclonal immunoglobulin use in critical illness: report of an expert consensus"],"prefix":"10.1186","volume":"6","author":[{"given":"Irene","family":"Coloretti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Giovanna","family":"Bignami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Busani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Clerici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Corcione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Corona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abele","family":"Donati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"De Pascale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Giuseppe","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Forfori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Grasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Imperatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Montrucchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinna Simone","family":"Mornese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik Roman","family":"Pognuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Francesca","family":"Rubulotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Paternoster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Pellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Siniscalchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Tascini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Tritapepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Girardis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,26]]},"reference":[{"issue":"8","key":"459_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW et al (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315(8):801\u2013810. https:\/\/doi.org\/10.1001\/jama.2016.0287","journal-title":"JAMA"},{"issue":"5","key":"459_CR2","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00134-026-08361-1","volume":"52","author":"HC Prescott","year":"2026","unstructured":"Prescott HC, Antonelli M, Alhazzani W et al (2026) Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026. Intensive Care Med 52(5):863\u2013936. https:\/\/doi.org\/10.1007\/s00134-026-08361-1","journal-title":"Intensive Care Med"},{"issue":"9","key":"459_CR3","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.3390\/microorganisms11092165","volume":"11","author":"G Papathanakos","year":"2023","unstructured":"Papathanakos G, Andrianopoulos I, Xenikakis M et al (2023) Clinical Sepsis Phenotypes in Critically Ill Patients. Microorganisms 11(9):2165. https:\/\/doi.org\/10.3390\/microorganisms11092165","journal-title":"Microorganisms"},{"issue":"20","key":"459_CR4","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.2019.5791","volume":"321","author":"CW Seymour","year":"2019","unstructured":"Seymour CW, Kennedy JN, Wang S et al (2019) Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. JAMA 321(20):2003\u20132017. https:\/\/doi.org\/10.1001\/jama.2019.5791","journal-title":"JAMA"},{"issue":"15","key":"459_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/ijms21155543","volume":"21","author":"D Jarczak","year":"2020","unstructured":"Jarczak D, Kluge S, Nierhaus A (2020) Use of Intravenous Immunoglobulins in Sepsis Therapy\u2014A Clinical View. Int J Mol Sci 21(15):15. https:\/\/doi.org\/10.3390\/ijms21155543","journal-title":"Int J Mol Sci"},{"issue":"5","key":"459_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3390\/cells13050439","volume":"13","author":"E Santacroce","year":"2024","unstructured":"Santacroce E, D\u2019Angerio M, Ciobanu AL et al (2024) Advances and Challenges in Sepsis Management: Modern Tools and Future Directions. Cells 13(5):439. https:\/\/doi.org\/10.3390\/cells13050439","journal-title":"Cells"},{"issue":"5","key":"459_CR7","first-page":"559","volume":"82","author":"S Busani","year":"2016","unstructured":"Busani S, Damiani E, Cavazzuti I, Donati A, Girardis M (2016) Intravenous immunoglobulin in septic shock: review of the mechanisms of action and meta-analysis of the clinical effectiveness. Minerva Anestesiol 82(5):559\u2013572","journal-title":"Minerva Anestesiol"},{"issue":"11","key":"459_CR8","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/nri2849","volume":"10","author":"MR Ehrenstein","year":"2010","unstructured":"Ehrenstein MR, Notley CA (2010) The importance of natural IgM: scavenger, protector and regulator. Nat Rev Immunol 10(11):778\u2013786. https:\/\/doi.org\/10.1038\/nri2849","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"459_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/cc10597","volume":"16","author":"M Shankar-Hari","year":"2012","unstructured":"Shankar-Hari M, Spencer J, Sewell WA, Rowan KM, Singer M (2012) Bench-to-bedside review: immunoglobulin therapy for sepsis - biological plausibility from a critical care perspective. Crit Care 16(2):206. https:\/\/doi.org\/10.1186\/cc10597","journal-title":"Crit Care"},{"issue":"5","key":"459_CR10","doi-asserted-by":"publisher","first-page":"R247","DOI":"10.1186\/cc13073","volume":"17","author":"EJ Giamarellos-Bourboulis","year":"2013","unstructured":"Giamarellos-Bourboulis EJ, Apostolidou E, Lada M et al (2013) Kinetics of circulating immunoglobulin M in sepsis: relationship with final outcome. Crit Care 17(5):R247. https:\/\/doi.org\/10.1186\/cc13073","journal-title":"Crit Care"},{"issue":"12","key":"459_CR11","first-page":"2677","volume":"35","author":"KG Kreymann","year":"2007","unstructured":"Kreymann KG, de Heer G, Nierhaus A, Kluge S (2007) Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock. Crit Care Med 35(12):2677\u20132685","journal-title":"Crit Care Med"},{"issue":"7","key":"459_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta16070","volume":"16","author":"MO Soares","year":"2012","unstructured":"Soares MO, Welton NJ, Harrison DA et al (2012) An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis. Health Technol Assess 16(7):1\u2013186. https:\/\/doi.org\/10.3310\/hta16070","journal-title":"Health Technol Assess"},{"key":"459_CR13","doi-asserted-by":"publisher","unstructured":"Alejandria MM, Lansang MAD, Dans LF, Iii JBM. Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock. Cochr Data Sys Rev. 2013;(9). https:\/\/doi.org\/10.1002\/14651858.CD001090.pub2","DOI":"10.1002\/14651858.CD001090.pub2"},{"key":"459_CR14","doi-asserted-by":"publisher","first-page":"2808203","DOI":"10.1155\/2017\/2808203","volume":"2017","author":"S Busani","year":"2017","unstructured":"Busani S, Roat E, Serafini G, Mantovani E, Biagioni E, Girardis M (2017) The Role of Adjunctive Therapies in Septic Shock by Gram Negative MDR\/XDR Infections. Can J Infect Dis Med Microbiol 2017:2808203. https:\/\/doi.org\/10.1155\/2017\/2808203","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"4","key":"459_CR15","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s00134-018-5143-7","volume":"44","author":"T Welte","year":"2018","unstructured":"Welte T, Dellinger RP, Ebelt H et al (2018) Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study). Intensive Care Med 44(4):438\u2013448. https:\/\/doi.org\/10.1007\/s00134-018-5143-7","journal-title":"Intensive Care Med"},{"issue":"1","key":"459_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04719-9","volume":"27","author":"M Singer","year":"2023","unstructured":"Singer M, Torres A, Heinz CC et al (2023) The immunomodulating activity of trimodulin (polyvalent IgM, IgA, IgG solution): a post hoc analysis of the phase II CIGMA trial. Crit Care 27(1):436. https:\/\/doi.org\/10.1186\/s13054-023-04719-9","journal-title":"Crit Care"},{"issue":"1","key":"459_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13613-019-0501-3","volume":"9","author":"J Cui","year":"2019","unstructured":"Cui J, Wei X, Lv H et al (2019) The clinical efficacy of intravenous IgM-enriched immunoglobulin (pentaglobin) in sepsis or septic shock: a meta-analysis with trial sequential analysis. Ann Intensive Care 9(1):27. https:\/\/doi.org\/10.1186\/s13613-019-0501-3","journal-title":"Ann Intensive Care"},{"issue":"1","key":"459_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40635-026-00877-6","volume":"14","author":"S David","year":"2026","unstructured":"David S, Leone M, Girardis M et al (2026) Clinical practice in using corticosteroids and adjunctive sepsis therapies at the bedside among European ICUs: an ESICM-endorsed survey. ICMx 14(1):33. https:\/\/doi.org\/10.1186\/s40635-026-00877-6","journal-title":"ICMx"},{"issue":"6","key":"459_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.accpm.2025.101643","volume":"44","author":"M Leone","year":"2025","unstructured":"Leone M, Bouras M, Bianchi A et al (2025) French guidelines on sepsis: a pragmatic frame to manage septic patients. Anaesthesia Critical Care & Pain Medicine 44(6):101643. https:\/\/doi.org\/10.1016\/j.accpm.2025.101643","journal-title":"Anaesthesia Critical Care & Pain Medicine"},{"key":"459_CR20","volume-title":"The Rand\/UCLA appropriateness method user\u2019s manual","year":"2001","unstructured":"Fitch K (ed) (2001) The Rand\/UCLA appropriateness method user\u2019s manual. Rand"},{"issue":"166","key":"459_CR21","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0123-2022","volume":"31","author":"MS Niederman","year":"2022","unstructured":"Niederman MS, Torres A (2022) Severe community-acquired pneumonia. Eur Respir Rev 31(166):220123. https:\/\/doi.org\/10.1183\/16000617.0123-2022","journal-title":"Eur Respir Rev"},{"issue":"1","key":"459_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191721","volume":"13","author":"M Ferrer","year":"2018","unstructured":"Ferrer M, Travierso C, Cilloniz C et al (2018) Severe community-acquired pneumonia: characteristics and prognostic factors in ventilated and non-ventilated patients. PLoS ONE 13(1):e0191721. https:\/\/doi.org\/10.1371\/journal.pone.0191721","journal-title":"PLoS ONE"},{"issue":"10","key":"459_CR23","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1080\/14787210.2021.1834848","volume":"20","author":"A Rombauts","year":"2022","unstructured":"Rombauts A, Abelenda-Alonso G, Cuervo G, Gudiol C, Carratal\u00e0 J (2022) Role of the inflammatory response in community-acquired pneumonia: clinical implications. Expert Rev Anti Infect Ther 20(10):1261\u20131274. https:\/\/doi.org\/10.1080\/14787210.2021.1834848","journal-title":"Expert Rev Anti Infect Ther"},{"key":"459_CR24","doi-asserted-by":"publisher","unstructured":"Martin-Loeches I, Torres A, Nagavci B, et al. ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia. Intensive Care Med\u00a0Published online April 4, 2023:1\u201318. https:\/\/doi.org\/10.1007\/s00134-023-07033-8","DOI":"10.1007\/s00134-023-07033-8"},{"issue":"12","key":"459_CR25","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1016\/S2213-2600(17)30444-7","volume":"5","author":"JF Bermejo-Martin","year":"2017","unstructured":"Bermejo-Martin JF, Almansa R, Martin-Fernandez M, Menendez R, Torres A (2017) Immunological profiling to assess disease severity and prognosis in community-acquired pneumonia. Lancet Respir Med 5(12):e35\u2013e36. https:\/\/doi.org\/10.1016\/S2213-2600(17)30444-7","journal-title":"Lancet Respir Med"},{"issue":"3\u20134","key":"459_CR26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2119\/molmed.2010.00138","volume":"17","author":"J Grommes","year":"2011","unstructured":"Grommes J, Soehnlein O (2011) Contribution of neutrophils to acute lung injury. Mol Med 17(3\u20134):293\u2013307. https:\/\/doi.org\/10.2119\/molmed.2010.00138","journal-title":"Mol Med"},{"issue":"1","key":"459_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41423-018-0024-0","volume":"16","author":"CM de Bont","year":"2019","unstructured":"de Bont CM, Boelens WC, Pruijn GJM (2019) NETosis, complement, and coagulation: a triangular relationship. Cell Mol Immunol 16(1):19\u201327. https:\/\/doi.org\/10.1038\/s41423-018-0024-0","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"459_CR28","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.98178","volume":"3","author":"E Lefran\u00e7ais","year":"2018","unstructured":"Lefran\u00e7ais E, Mallavia B, Zhuo H, Calfee CS, Looney MR (2018) Maladaptive role of neutrophil extracellular traps in pathogen-induced lung injury. JCI Insight 3(3):e98178. https:\/\/doi.org\/10.1172\/jci.insight.98178","journal-title":"JCI Insight"},{"issue":"11","key":"459_CR29","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.3390\/biomedicines11113022","volume":"11","author":"C Schmidt","year":"2023","unstructured":"Schmidt C, Wei\u00dfm\u00fcller S, Heinz CC (2023) Multifaceted Tissue-Protective Functions of Polyvalent Immunoglobulin Preparations in Severe Infections-Interactions with Neutrophils, Complement, and Coagulation Pathways. Biomedicines 11(11):3022. https:\/\/doi.org\/10.3390\/biomedicines11113022","journal-title":"Biomedicines"},{"issue":"3","key":"459_CR30","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1165\/rcmb.2018-0272OC","volume":"60","author":"X Gao","year":"2019","unstructured":"Gao X, Yan X, Yin Y et al (2019) Therapeutic Targeting of Apoptosis Inhibitor of Macrophage\/CD5L in Sepsis. Am J Respir Cell Mol Biol 60(3):323\u2013334. https:\/\/doi.org\/10.1165\/rcmb.2018-0272OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"459_CR31","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nm836","volume":"9","author":"M Basta","year":"2003","unstructured":"Basta M, Van Goor F, Luccioli S et al (2003) F(ab)\u20192-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins. Nat Med 9(4):431\u2013438. https:\/\/doi.org\/10.1038\/nm836","journal-title":"Nat Med"},{"issue":"16","key":"459_CR32","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1016\/j.molimm.2008.07.012","volume":"45","author":"M Basta","year":"2008","unstructured":"Basta M (2008) Ambivalent effect of immunoglobulins on the complement system: activation versus inhibition. Mol Immunol 45(16):4073\u20134079. https:\/\/doi.org\/10.1016\/j.molimm.2008.07.012","journal-title":"Mol Immunol"},{"issue":"Suppl 1","key":"459_CR33","doi-asserted-by":"publisher","first-page":"P27","DOI":"10.1186\/cc8259","volume":"14","author":"T Ikeda","year":"2010","unstructured":"Ikeda T, Ikeda K, Taniuchi H, Suda S, Takahashi Y (2010) Background factors in patients receiving immunoglobulin administration and changes in sepsis markers. Crit Care 14(Suppl 1):P27. https:\/\/doi.org\/10.1186\/cc8259","journal-title":"Crit Care"},{"issue":"3","key":"459_CR34","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jcrc.2015.02.012","volume":"30","author":"H Ishikura","year":"2015","unstructured":"Ishikura H, Nakamura Y, Kawano Y et al (2015) Intravenous immunoglobulin improves sepsis-induced coagulopathy: A retrospective, single-center observational study. J Crit Care 30(3):579\u2013583. https:\/\/doi.org\/10.1016\/j.jcrc.2015.02.012","journal-title":"J Crit Care"},{"issue":"1","key":"459_CR35","doi-asserted-by":"publisher","first-page":"P62","DOI":"10.1186\/cc14142","volume":"19","author":"T Ikeda","year":"2015","unstructured":"Ikeda T, Ono S, Ueno T, Tanaka H, Suda S (2015) Changes in procalcitonin and presepsin before and after immunoglobulin administration in septic patients. Crit Care 19(1):P62. https:\/\/doi.org\/10.1186\/cc14142","journal-title":"Crit Care"},{"key":"459_CR36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jcrc.2016.05.005","volume":"35","author":"MC de la Torre","year":"2016","unstructured":"de la Torre MC, Palomera E, Serra-Prat M et al (2016) IgG2 as an independent risk factor for mortality in patients with community-acquired pneumonia. J Crit Care 35:115\u2013119. https:\/\/doi.org\/10.1016\/j.jcrc.2016.05.005","journal-title":"J Crit Care"},{"issue":"3","key":"459_CR37","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.jcv.2013.09.006","volume":"58","author":"M Justel","year":"2013","unstructured":"Justel M, Socias L, Almansa R et al (2013) IgM levels in plasma predict outcome in severe pandemic influenza. J Clin Virol 58(3):564\u2013567. https:\/\/doi.org\/10.1016\/j.jcv.2013.09.006","journal-title":"J Clin Virol"},{"issue":"2","key":"459_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/shk.0b013e318067df15","volume":"29","author":"SN Stehr","year":"2008","unstructured":"Stehr SN, Knels L, Weissflog C et al (2008) Effects of IGM-enriched solution on polymorphonuclear neutrophil function, bacterial clearance, and lung histology in endotoxemia. Shock 29(2):167\u2013172. https:\/\/doi.org\/10.1097\/shk.0b013e318067df15","journal-title":"Shock"},{"issue":"1","key":"459_CR39","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3109\/13880209.2014.910535","volume":"53","author":"I Ates","year":"2015","unstructured":"Ates I, Dogan N, Aksoy M, Hal\u0131c\u0131 Z, G\u00fcndogdu C, Keles MS (2015) The protective effects of IgM-enriched immunoglobulin and erythropoietin on the lung and small intestine tissues of rats with induced sepsis: biochemical and histopathological evaluation. Pharm Biol 53(1):78\u201384. https:\/\/doi.org\/10.3109\/13880209.2014.910535","journal-title":"Pharm Biol"},{"issue":"1","key":"459_CR40","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1097\/CCM.0000000000001271","volume":"44","author":"H Katoh","year":"2016","unstructured":"Katoh H, Yasumoto H, Shimizu M et al (2016) IV immunoglobulin for acute lung injury and bacteremia in Pseudomonas aeruginosa pneumonia*. Crit Care Med 44(1):e12. https:\/\/doi.org\/10.1097\/CCM.0000000000001271","journal-title":"Crit Care Med"},{"issue":"3","key":"459_CR41","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1272\/jnms.JNMS.2020_87-303","volume":"87","author":"J Hagiwara","year":"2020","unstructured":"Hagiwara J, Yamada M, Motoda N, Yokota H (2020) Intravenous immunoglobulin attenuates cecum ligation and puncture-induced acute lung injury by inhibiting apoptosis of alveolar epithelial cells. J Nippon Med Sch 87(3):129\u2013137. https:\/\/doi.org\/10.1272\/jnms.JNMS.2020_87-303","journal-title":"J Nippon Med Sch"},{"key":"459_CR42","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/s40001-024-02008-x","volume":"29","author":"A Agafina","year":"2024","unstructured":"Agafina A, Aguiar VC, Rossovskaya M et al (2024) Efficacy and safety of trimodulin in patients with severe COVID-19: results from a randomised, placebo-controlled, double-blind, multicentre, phase II trial (ESsCOVID). Eur J Med Res 29:418. https:\/\/doi.org\/10.1186\/s40001-024-02008-x","journal-title":"Eur J Med Res"},{"issue":"1","key":"459_CR43","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13054-022-04059-0","volume":"26","author":"T Rahmel","year":"2022","unstructured":"Rahmel T, Kraft F, Haberl H et al (2022) Intravenous IgM-enriched immunoglobulins in critical COVID-19: a multicentre propensity-weighted cohort study. Crit Care 26(1):204. https:\/\/doi.org\/10.1186\/s13054-022-04059-0","journal-title":"Crit Care"},{"issue":"10","key":"459_CR44","doi-asserted-by":"publisher","first-page":"884","DOI":"10.23736\/S0375-9393.23.17244-0","volume":"89","author":"C Tascini","year":"2023","unstructured":"Tascini C, Cotrufo M, Sozio E et al (2023) Potential role of IgM-enriched immunoglobulin as adjuvant treatment in severe SARS-CoV-2 infection. Minerva Anestesiol 89(10):884\u2013894. https:\/\/doi.org\/10.23736\/S0375-9393.23.17244-0","journal-title":"Minerva Anestesiol"},{"issue":"1","key":"459_CR45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13017-021-00387-8","volume":"16","author":"M Sartelli","year":"2021","unstructured":"Sartelli M, Coccolini F, Kluger Y et al (2021) WSES\/GAIS\/SIS-E\/WSIS\/AAST global clinical pathways for patients with intra-abdominal infections. World J Emerg Surg 16(1):49. https:\/\/doi.org\/10.1186\/s13017-021-00387-8","journal-title":"World J Emerg Surg"},{"key":"459_CR46","doi-asserted-by":"publisher","unstructured":"Sakr Y, Jaschinski U, Wittebole X, et al. Sepsis in intensive care unit patients: worldwide data from the intensive care over nations audit. Open Forum Infect Dis 2018;5(12):ofy313. https:\/\/doi.org\/10.1093\/ofid\/ofy313","DOI":"10.1093\/ofid\/ofy313"},{"issue":"Suppl 1","key":"459_CR47","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1007\/s001340051119","volume":"26","author":"J Cohen","year":"2000","unstructured":"Cohen J (2000) The detection and interpretation of endotoxaemia. Intensive Care Med 26(Suppl 1):S51-56. https:\/\/doi.org\/10.1007\/s001340051119","journal-title":"Intensive Care Med"},{"issue":"3","key":"459_CR48","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1086\/422254","volume":"190","author":"JC Marshall","year":"2004","unstructured":"Marshall JC, Foster D, Vincent JL et al (2004) Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis 190(3):527\u2013534. https:\/\/doi.org\/10.1086\/422254","journal-title":"J Infect Dis"},{"issue":"3","key":"459_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/cc7934","volume":"13","author":"F Valenza","year":"2009","unstructured":"Valenza F, Fagnani L, Coppola S et al (2009) Prevalence of endotoxemia after surgery and its association with ICU length of stay. Crit Care 13(3):R102. https:\/\/doi.org\/10.1186\/cc7934","journal-title":"Crit Care"},{"issue":"4","key":"459_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/cc11462","volume":"16","author":"JC Hurley","year":"2012","unstructured":"Hurley JC, Guidet B, Offenstadt G, Maury E (2012) Endotoxemia and mortality prediction in ICU and other settings: underlying risk and co-detection of gram negative bacteremia are confounders. Crit Care 16(4):R148. https:\/\/doi.org\/10.1186\/cc11462","journal-title":"Crit Care"},{"issue":"5","key":"459_CR51","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.jcrc.2013.02.005","volume":"28","author":"E Biagioni","year":"2013","unstructured":"Biagioni E, Venturelli C, Klein DJ et al (2013) Endotoxin activity levels as a prediction tool for risk of deterioration in patients with sepsis not admitted to the intensive care unit: a pilot observational study. J Crit Care 28(5):612\u2013617. https:\/\/doi.org\/10.1016\/j.jcrc.2013.02.005","journal-title":"J Crit Care"},{"issue":"1","key":"459_CR52","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/shk.0b013e318123e5a6","volume":"29","author":"JN Hoffmann","year":"2008","unstructured":"Hoffmann JN, Fertmann JM, Vollmar B, Laschke MW, Jauch KW, Menger MD (2008) Immunoglobulin M-enriched human intravenous immunoglobulins reduce leukocyte-endothelial cell interactions and attenuate microvascular perfusion failure in normotensive endotoxemia. Shock 29(1):133. https:\/\/doi.org\/10.1097\/shk.0b013e318123e5a6","journal-title":"Shock"},{"issue":"8","key":"459_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0160907","volume":"11","author":"S Wand","year":"2016","unstructured":"Wand S, Klages M, Kirbach C et al (2016) IgM-enriched immunoglobulin attenuates systemic endotoxin activity in early severe sepsis: a before-after cohort study. PLoS ONE 11(8):e0160907. https:\/\/doi.org\/10.1371\/journal.pone.0160907","journal-title":"PLoS ONE"},{"issue":"10","key":"459_CR54","first-page":"479","volume":"9","author":"HB Reith","year":"2004","unstructured":"Reith HB, Rauchschwalbe SK, Mittelk\u00f6tter U et al (2004) IgM-enriched immunoglobulin (pentaglobin) positively influences the course of post-surgical intra-abdominal infections. Eur J Med Res 9(10):479\u2013484","journal-title":"Eur J Med Res"},{"issue":"9","key":"459_CR55","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1097\/00003246-199109000-00003","volume":"19","author":"I Schedel","year":"1991","unstructured":"Schedel I, Dreikhausen U, Nentwig B et al (1991) Treatment of gram-negative septic shock with an immunoglobulin preparation: a prospective, randomized clinical trial. Crit Care Med 19(9):1104\u20131113. https:\/\/doi.org\/10.1097\/00003246-199109000-00003","journal-title":"Crit Care Med"},{"issue":"3","key":"459_CR56","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S1473-3099(13)70001-X","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss RS, Monneret G, Payen D (2013) Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 13(3):260\u2013268. https:\/\/doi.org\/10.1016\/S1473-3099(13)70001-X","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"459_CR57","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/SHK.0000000000000234","volume":"42","author":"AM Drewry","year":"2014","unstructured":"Drewry AM, Samra N, Skrupky LP, Fuller BM, Compton SM, Hotchkiss RS (2014) Persistent lymphopenia after diagnosis of sepsis predicts mortality. Shock 42(5):383\u2013391. https:\/\/doi.org\/10.1097\/SHK.0000000000000234","journal-title":"Shock"},{"issue":"12","key":"459_CR58","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nri3552","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss RS, Monneret G, Payen D (2013) Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 13(12):862\u2013874. https:\/\/doi.org\/10.1038\/nri3552","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"459_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2019.12.006","volume":"225","author":"S Stracquadanio","year":"2020","unstructured":"Stracquadanio S, Lo Verde F, Cialfi A, Zega A, Stefani S, Cafiso V (2020) Titration of Igs contained in an intravenous IgM-enriched preparation against selected pathogens involved in sepsis. Immunobiology 225(2):151897. https:\/\/doi.org\/10.1016\/j.imbio.2019.12.006","journal-title":"Immunobiology"},{"issue":"6","key":"459_CR60","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.cmi.2016.01.021","volume":"22","author":"EJ Giamarellos-Bourboulis","year":"2016","unstructured":"Giamarellos-Bourboulis EJ, Tziolos N, Routsi C et al (2016) Improving outcomes of severe infections by multidrug-resistant pathogens with polyclonal IgM-enriched immunoglobulins. Clin Microbiol Infect 22(6):499\u2013506. https:\/\/doi.org\/10.1016\/j.cmi.2016.01.021","journal-title":"Clin Microbiol Infect"},{"key":"459_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhlto.2025.100231","volume":"8","author":"SN Feng","year":"2025","unstructured":"Feng SN, Akbar AF, Zhou AL et al (2025) Increasing risk of postlung transplant hospitalizations for infection: an analysis of recent trends. JHLT Open 8:100231. https:\/\/doi.org\/10.1016\/j.jhlto.2025.100231","journal-title":"JHLT Open"},{"issue":"5","key":"459_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2023.151486","volume":"43","author":"J Bharati","year":"2023","unstructured":"Bharati J, Anandh U, Kotton CN, Mueller T, Shingada AK, Ramachandran R (2023) Diagnosis, prevention, and treatment of infections in kidney transplantation. Semin Nephrol 43(5):151486. https:\/\/doi.org\/10.1016\/j.semnephrol.2023.151486","journal-title":"Semin Nephrol"},{"issue":"1","key":"459_CR63","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ccc.2018.08.010","volume":"35","author":"M Alsaeed","year":"2019","unstructured":"Alsaeed M, Husain S (2019) Infections in Heart and Lung Transplant Recipients. Crit Care Clin 35(1):75\u201393. https:\/\/doi.org\/10.1016\/j.ccc.2018.08.010","journal-title":"Crit Care Clin"},{"issue":"5","key":"459_CR64","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00134-019-05597-y","volume":"45","author":"JF Timsit","year":"2019","unstructured":"Timsit JF, Sonneville R, Kalil AC et al (2019) Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients. Intensive Care Med 45(5):573\u2013591. https:\/\/doi.org\/10.1007\/s00134-019-05597-y","journal-title":"Intensive Care Med"},{"issue":"20","key":"459_CR65","doi-asserted-by":"publisher","first-page":"6211","DOI":"10.3748\/wjg.v20.i20.6211","volume":"20","author":"SI Kim","year":"2014","unstructured":"Kim SI (2014) Bacterial infection after liver transplantation. World J Gastroenterol 20(20):6211\u20136220. https:\/\/doi.org\/10.3748\/wjg.v20.i20.6211","journal-title":"World J Gastroenterol"},{"key":"459_CR66","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ajt.12093","volume":"13","author":"M Green","year":"2013","unstructured":"Green M (2013) Introduction: infections in solid organ transplantation. Am J Transplant 13:3\u20138. https:\/\/doi.org\/10.1111\/ajt.12093","journal-title":"Am J Transplant"},{"issue":"5","key":"459_CR67","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1097\/01.CCM.0000215452.84291.C6","volume":"34","author":"M Hentrich","year":"2006","unstructured":"Hentrich M, Fehnle K, Ostermann H et al (2006) IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial. Crit Care Med 34(5):1319\u20131325. https:\/\/doi.org\/10.1097\/01.CCM.0000215452.84291.C6","journal-title":"Crit Care Med"},{"issue":"1","key":"459_CR68","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s44158-024-00165-3","volume":"4","author":"M Girardis","year":"2024","unstructured":"Girardis M, Coloretti I, Antonelli M et al (2024) Adjunctive immunotherapeutic agents in patients with sepsis and septic shock: a multidisciplinary consensus of 23. J Anesth Analg Crit Care 4(1):28. https:\/\/doi.org\/10.1186\/s44158-024-00165-3","journal-title":"J Anesth Analg Crit Care"},{"issue":"3","key":"459_CR69","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/00044067-200507000-00004","volume":"16","author":"GG Page","year":"2005","unstructured":"Page GG (2005) Surgery-induced immunosuppression and postoperative pain management. AACN Clin Issues 16(3):302\u2013309. https:\/\/doi.org\/10.1097\/00044067-200507000-00004","journal-title":"AACN Clin Issues"},{"issue":"3","key":"459_CR70","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.bbi.2009.02.010","volume":"24","author":"I Bartal","year":"2010","unstructured":"Bartal I, Melamed R, Greenfeld K et al (2010) Immune perturbations in patients along the perioperative period: alterations in cell surface markers and leukocyte subtypes before and after surgery. Brain Behav Immun 24(3):376\u2013386. https:\/\/doi.org\/10.1016\/j.bbi.2009.02.010","journal-title":"Brain Behav Immun"},{"issue":"4","key":"459_CR71","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.bbi.2006.12.006","volume":"21","author":"K Greenfeld","year":"2007","unstructured":"Greenfeld K, Avraham R, Benish M et al (2007) Immune suppression while awaiting surgery and following it: dissociations between plasma cytokine levels, their induced production, and NK cell cytotoxicity. Brain Behav Immun 21(4):503\u2013513. https:\/\/doi.org\/10.1016\/j.bbi.2006.12.006","journal-title":"Brain Behav Immun"},{"issue":"42","key":"459_CR72","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000022459","volume":"99","author":"X Chen","year":"2020","unstructured":"Chen X, Yuan S, Zhang J (2020) Correlation study between blood cytokines and lymphocytes in early postoperative critical patients with compromised immune function. Medicine (Baltimore) 99(42):e22459. https:\/\/doi.org\/10.1097\/MD.0000000000022459","journal-title":"Medicine (Baltimore)"},{"issue":"2 Suppl 2","key":"459_CR73","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.jaci.2009.09.046","volume":"125","author":"HW Schroeder","year":"2010","unstructured":"Schroeder HW, Cavacini L (2010) Structure and function of immunoglobulins. J Allergy Clin Immunol 125(2 Suppl 2):S41-52. https:\/\/doi.org\/10.1016\/j.jaci.2009.09.046","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"459_CR74","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00281-014-0466-0","volume":"37","author":"SR Elluru","year":"2015","unstructured":"Elluru SR, Kaveri SV, Bayry J (2015) The protective role of immunoglobulins in fungal infections and inflammation. Semin Immunopathol 37(2):187\u2013197. https:\/\/doi.org\/10.1007\/s00281-014-0466-0","journal-title":"Semin Immunopathol"},{"issue":"10","key":"459_CR75","doi-asserted-by":"publisher","first-page":"5755","DOI":"10.4049\/jimmunol.0901638","volume":"184","author":"KS Subramaniam","year":"2010","unstructured":"Subramaniam KS, Datta K, Quintero E, Manix C, Marks MS, Pirofski LA (2010) The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans. J Immunol 184(10):5755\u20135767. https:\/\/doi.org\/10.4049\/jimmunol.0901638","journal-title":"J Immunol"},{"issue":"6","key":"459_CR76","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/MOT.0b013e3283186bbc","volume":"13","author":"S Mawhorter","year":"2008","unstructured":"Mawhorter S, Yamani MH (2008) Hypogammaglobulinemia and infection risk in solid organ transplant recipients. Curr Opin Organ Transplant 13(6):581\u2013585. https:\/\/doi.org\/10.1097\/MOT.0b013e3283186bbc","journal-title":"Curr Opin Organ Transplant"},{"issue":"10","key":"459_CR77","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1111\/ajt.12401","volume":"13","author":"DF Florescu","year":"2013","unstructured":"Florescu DF, Kalil AC, Qiu F, Schmidt CM, Sandkovsky U (2013) What is the impact of hypogammaglobulinemia on the rate of infections and survival in solid organ transplantation? A meta-analysis Am J Transplant 13(10):2601\u20132610. https:\/\/doi.org\/10.1111\/ajt.12401","journal-title":"A meta-analysis Am J Transplant"},{"issue":"3","key":"459_CR78","doi-asserted-by":"publisher","first-page":"E277","DOI":"10.1111\/j.1399-0012.2012.01653.x","volume":"26","author":"J Carbone","year":"2012","unstructured":"Carbone J, Sarmiento E, Del Pozo N et al (2012) Restoration of humoral immunity after intravenous immunoglobulin replacement therapy in heart recipients with post-transplant antibody deficiency and severe infections. Clin Transplant 26(3):E277-283. https:\/\/doi.org\/10.1111\/j.1399-0012.2012.01653.x","journal-title":"Clin Transplant"},{"issue":"6","key":"459_CR79","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1111\/tid.12610","volume":"18","author":"E Sarmiento","year":"2016","unstructured":"Sarmiento E, Diez P, Arraya M et al (2016) Early intravenous immunoglobulin replacement in hypogammaglobulinemic heart transplant recipients: results of a clinical trial. Transpl Infect Dis 18(6):832\u2013843. https:\/\/doi.org\/10.1111\/tid.12610","journal-title":"Transpl Infect Dis"},{"key":"459_CR80","unstructured":"Gonz\u00e0lez-Quintela A, Alende MR, Gamallo R, et al. Serum immunoglobulins (IgG, IgA, IgM) in chronic hepatitis C. A comparison with non-cirrhotic alcoholic liver disease. Hepatogastroenterol. 2003;50(54):2121\u20132126."},{"issue":"5","key":"459_CR81","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/01.tp.0000180531.66518.9e","volume":"81","author":"S Doron","year":"2006","unstructured":"Doron S, Ruthazer R, Werner BG, Rabson A, Snydman DR (2006) Hypogammaglobulinemia in liver transplant recipients: incidence, timing, risk factors, and outcomes. Transplantation 81(5):697\u2013703. https:\/\/doi.org\/10.1097\/01.tp.0000180531.66518.9e","journal-title":"Transplantation"},{"issue":"2","key":"459_CR82","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/tid.12188","volume":"16","author":"T Yoshizumi","year":"2014","unstructured":"Yoshizumi T, Shirabe K, Ikegami T et al (2014) Decreased immunoglobulin G levels after living-donor liver transplantation is a risk factor for bacterial infection and sepsis. Transpl Infect Dis 16(2):225\u2013231. https:\/\/doi.org\/10.1111\/tid.12188","journal-title":"Transpl Infect Dis"},{"issue":"7","key":"459_CR83","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13625","volume":"33","author":"S Bourassa-Blanchette","year":"2019","unstructured":"Bourassa-Blanchette S, Patel V, Knoll GA et al (2019) Clinical outcomes of polyvalent immunoglobulin use in solid organ transplant recipients: A systematic review and meta-analysis - Part II: Non-kidney transplant. Clin Transplant 33(7):e13625. https:\/\/doi.org\/10.1111\/ctr.13625","journal-title":"Clin Transplant"},{"issue":"6","key":"459_CR84","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13560","volume":"33","author":"S Bourassa-Blanchette","year":"2019","unstructured":"Bourassa-Blanchette S, Knoll GA, Hutton B et al (2019) Clinical outcomes of polyvalent immunoglobulin use in solid organ transplant recipients: a systematic review and meta-analysis. Clin Transplant 33(6):e13560. https:\/\/doi.org\/10.1111\/ctr.13560","journal-title":"Clin Transplant"},{"issue":"2","key":"459_CR85","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41575-021-00520-7","volume":"19","author":"A Albillos","year":"2022","unstructured":"Albillos A, Martin-Mateos R, Van der Merwe S, Wiest R, Jalan R, \u00c1lvarez-Mon M (2022) Cirrhosis-associated immune dysfunction. Nat Rev Gastroenterol Hepatol 19(2):112\u2013134. https:\/\/doi.org\/10.1038\/s41575-021-00520-7","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"459_CR86","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1445-2197.1997.tb01938.x","volume":"67","author":"SP Pillay","year":"1997","unstructured":"Pillay SP, Wynter C, Lynch S, Wall D, Balderson G, Strong R (1997) Endotoxin levels in donors and recipients during orthotopic liver transplantation. Aust N Z J Surg 67(4):187\u2013191. https:\/\/doi.org\/10.1111\/j.1445-2197.1997.tb01938.x","journal-title":"Aust N Z J Surg"},{"issue":"16","key":"459_CR87","doi-asserted-by":"publisher","first-page":"4965","DOI":"10.3390\/jcm13164965","volume":"13","author":"E Roat","year":"2024","unstructured":"Roat E, Tosi M, Coloretti I et al (2024) Perioperative use of IgM-enriched immunoglobulins in liver transplantation recipients at high risk for infections: a preliminary study. J Clin Med 13(16):4965. https:\/\/doi.org\/10.3390\/jcm13164965","journal-title":"J Clin Med"},{"key":"459_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2023.154258","volume":"75","author":"E Antonucci","year":"2023","unstructured":"Antonucci E, Polo T, Giovini M et al (2023) Refractory septic shock and alternative wordings: a systematic review of literature. J Crit Care 75:154258. https:\/\/doi.org\/10.1016\/j.jcrc.2023.154258","journal-title":"J Crit Care"},{"issue":"11","key":"459_CR89","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W et al (2021) Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med 49(11):e1063\u2013e1143. https:\/\/doi.org\/10.1097\/CCM.0000000000005337","journal-title":"Crit Care Med"},{"key":"459_CR90","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000324022","volume":"17","author":"DLW Chong","year":"2011","unstructured":"Chong DLW, Sriskandan S (2011) Pro-inflammatory mechanisms in sepsis. Contrib Microbiol 17:86\u2013107. https:\/\/doi.org\/10.1159\/000324022","journal-title":"Contrib Microbiol"},{"issue":"1","key":"459_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2016.45","volume":"2","author":"RS Hotchkiss","year":"2016","unstructured":"Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent JL (2016) Sepsis and septic shock. Nat Rev Dis Primers 2(1):1. https:\/\/doi.org\/10.1038\/nrdp.2016.45","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"459_CR92","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.it.2012.09.004","volume":"34","author":"M Bosmann","year":"2013","unstructured":"Bosmann M, Ward PA (2013) The inflammatory response in sepsis. Trends Immunol 34(3):129\u2013136. https:\/\/doi.org\/10.1016\/j.it.2012.09.004","journal-title":"Trends Immunol"},{"issue":"3","key":"459_CR93","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1086\/376630","volume":"37","author":"J Darenberg","year":"2003","unstructured":"Darenberg J, Ihendyane N, Sj\u00f6lin J et al (2003) Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis 37(3):333\u2013340. https:\/\/doi.org\/10.1086\/376630","journal-title":"Clin Infect Dis"},{"issue":"3","key":"459_CR94","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1089\/sur.2016.200","volume":"18","author":"CS Cocanour","year":"2017","unstructured":"Cocanour CS, Chang P, Huston JM et al (2017) Management and Novel Adjuncts of Necrotizing Soft Tissue Infections. Surg Infect (Larchmt) 18(3):250\u2013272. https:\/\/doi.org\/10.1089\/sur.2016.200","journal-title":"Surg Infect (Larchmt)"},{"issue":"6","key":"459_CR95","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/cid\/ciu449","volume":"59","author":"A Linn\u00e9r","year":"2014","unstructured":"Linn\u00e9r A, Darenberg J, Sj\u00f6lin J, Henriques-Normark B, Norrby-Teglund A (2014) Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study. Clin Infect Dis 59(6):851\u2013857. https:\/\/doi.org\/10.1093\/cid\/ciu449","journal-title":"Clin Infect Dis"},{"issue":"11","key":"459_CR96","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s00134-017-4786-0","volume":"43","author":"MB Madsen","year":"2017","unstructured":"Madsen MB, Hjortrup PB, Hansen MB et al (2017) Immunoglobulin G for patients with necrotising soft tissue infection (INSTINCT): a randomised, blinded, placebo-controlled trial. Intensive Care Med 43(11):1585\u20131593. https:\/\/doi.org\/10.1007\/s00134-017-4786-0","journal-title":"Intensive Care Med"},{"issue":"7","key":"459_CR97","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/cid\/ciw871","volume":"64","author":"SS Kadri","year":"2017","unstructured":"Kadri SS, Swihart BJ, Bonne SL et al (2017) Impact of intravenous immunoglobulin on survival in necrotizing fasciitis with vasopressor-dependent shock: a propensity score-matched analysis from 130 US hospitals. Clin Infect Dis 64(7):877\u2013885. https:\/\/doi.org\/10.1093\/cid\/ciw871","journal-title":"Clin Infect Dis"},{"issue":"2","key":"459_CR98","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00134-017-4957-z","volume":"44","author":"C Tascini","year":"2018","unstructured":"Tascini C, Fraganza F, Salani F et al (2018) Potential role of IgM-enriched immunoglobulin as adjuvant treatment for invasive meningococcal disease. Intensive Care Med 44(2):261\u2013262. https:\/\/doi.org\/10.1007\/s00134-017-4957-z","journal-title":"Intensive Care Med"},{"key":"459_CR99","doi-asserted-by":"publisher","unstructured":"Oliveira DC de, Oliveira Filho JB de, Silva RF, et al. Sepsis in the postoperative period of cardiac surgery: problem description. Arq Bras Cardiol. 2010;94(3):332\u2013336, 352\u2013356. https:\/\/doi.org\/10.1590\/s0066-782x2010000300012","DOI":"10.1590\/s0066-782x2010000300012"},{"issue":"7625","key":"459_CR100","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1136\/bmj.39346.495880.AE","volume":"335","author":"A Lever","year":"2007","unstructured":"Lever A, Mackenzie I (2007) Sepsis: definition, epidemiology, and diagnosis. BMJ 335(7625):879\u2013883. https:\/\/doi.org\/10.1136\/bmj.39346.495880.AE","journal-title":"BMJ"},{"issue":"3","key":"459_CR101","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.bja.2017.10.018","volume":"120","author":"SH Howitt","year":"2018","unstructured":"Howitt SH, Herring M, Malagon I, McCollum CN, Grant SW (2018) Incidence and outcomes of sepsis after cardiac surgery as defined by the Sepsis-3 guidelines. Br J Anaesth 120(3):509\u2013516. https:\/\/doi.org\/10.1016\/j.bja.2017.10.018","journal-title":"Br J Anaesth"},{"issue":"4","key":"459_CR102","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1097\/00000539-199710000-00011","volume":"85","author":"RI Hall","year":"1997","unstructured":"Hall RI, Smith MS, Rocker G (1997) The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacological considerations. Anesth Analg 85(4):766\u2013782. https:\/\/doi.org\/10.1097\/00000539-199710000-00011","journal-title":"Anesth Analg"},{"issue":"3","key":"459_CR103","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1051\/ject\/200537272","volume":"37","author":"J Halter","year":"2005","unstructured":"Halter J, Steinberg J, Fink G et al (2005) Evidence of systemic cytokine release in patients undergoing cardiopulmonary bypass. J Extra Corpor Technol 37(3):272\u2013277","journal-title":"J Extra Corpor Technol"},{"key":"459_CR104","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/801643","volume":"2014","author":"MT Dieterlen","year":"2014","unstructured":"Dieterlen MT, Bittner HB, Tarnok A et al (2014) Flow cytometric evaluation of T cell activation markers after cardiopulmonary bypass. Surg Res Pract 2014:801643. https:\/\/doi.org\/10.1155\/2014\/801643","journal-title":"Surg Res Pract"},{"issue":"9","key":"459_CR105","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1177\/000331970005100906","volume":"51","author":"E Boelke","year":"2000","unstructured":"Boelke E, Storck M, Buttenschoen K, Berger D, Hannekum A (2000) Endotoxemia and mediator release during cardiac surgery. Angiology 51(9):743\u2013749. https:\/\/doi.org\/10.1177\/000331970005100906","journal-title":"Angiology"},{"issue":"4","key":"459_CR106","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ejcts.2010.06.011","volume":"39","author":"S Kats","year":"2011","unstructured":"Kats S, Sch\u00f6nberger JPAM, Brands R, Seinen W, van Oeveren W (2011) Endotoxin release in cardiac surgery with cardiopulmonary bypass: pathophysiology and possible therapeutic strategies. An update Eur J Cardiothorac Surg 39(4):451\u2013458. https:\/\/doi.org\/10.1016\/j.ejcts.2010.06.011","journal-title":"An update Eur J Cardiothorac Surg"},{"issue":"1","key":"459_CR107","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/labinvest.2009.119","volume":"90","author":"RB McILwain","year":"2010","unstructured":"McILwain RB, Timpa JG, Kurundkar AR et al (2010) Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine. Lab Invest 90(1):128\u2013139. https:\/\/doi.org\/10.1038\/labinvest.2009.119","journal-title":"Lab Invest"},{"key":"459_CR108","doi-asserted-by":"publisher","unstructured":"Radice RP, Martelli G, D\u2019Amora M, et al. Sepsis after cardiac surgery: preliminary analysis of cytokines gene expression. J Cardio Vas Anesthesia. 2024;38(12, Supplement):85. https:\/\/doi.org\/10.1053\/j.jvca.2024.09.132","DOI":"10.1053\/j.jvca.2024.09.132"},{"issue":"1","key":"459_CR109","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13613-020-00740-1","volume":"10","author":"A Nierhaus","year":"2020","unstructured":"Nierhaus A, Berlot G, Kindgen-Milles D, M\u00fcller E, Girardis M (2020) Best-practice IgM- and IgA-enriched immunoglobulin use in patients with sepsis. Ann Intensive Care 10(1):132. https:\/\/doi.org\/10.1186\/s13613-020-00740-1","journal-title":"Ann Intensive Care"},{"issue":"9","key":"459_CR110","doi-asserted-by":"publisher","first-page":"314","DOI":"10.31083\/j.rcm2309314","volume":"23","author":"G Paternoster","year":"2022","unstructured":"Paternoster G, De Rosa S, Bertini P et al (2022) Comparative Effectiveness of Combined IgM-Enriched Immunoglobulin and Extracorporeal Blood Purification Plus Standard Care Versus Standard Care for Sepsis and Septic Shock after Cardiac Surgery. Rev Cardiovasc Med 23(9):314. https:\/\/doi.org\/10.31083\/j.rcm2309314","journal-title":"Rev Cardiovasc Med"},{"issue":"4","key":"459_CR111","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1053\/j.jvca.2005.05.003","volume":"19","author":"S Buda","year":"2005","unstructured":"Buda S, Riefolo A, Biscione R et al (2005) Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery. J Cardiothorac Vasc Anesth 19(4):440\u2013445. https:\/\/doi.org\/10.1053\/j.jvca.2005.05.003","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"5","key":"459_CR112","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1473-3099(11)70056-1","volume":"11","author":"G Cornaglia","year":"2011","unstructured":"Cornaglia G, Giamarellou H, Rossolini GM (2011) Metallo-\u03b2-lactamases: a last frontier for \u03b2-lactams? Lancet Infect Dis 11(5):381\u2013393. https:\/\/doi.org\/10.1016\/S1473-3099(11)70056-1","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"459_CR113","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jhin.2004.06.007","volume":"58","author":"KB Laupland","year":"2004","unstructured":"Laupland KB, Kirkpatrick AW, Church DL, Ross T, Gregson DB (2004) Intensive-care-unit-acquired bloodstream infections in a regional critically ill population. J Hosp Infect 58(2):137\u2013145. https:\/\/doi.org\/10.1016\/j.jhin.2004.06.007","journal-title":"J Hosp Infect"},{"issue":"1","key":"459_CR114","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/cid\/cir202","volume":"53","author":"N Gupta","year":"2011","unstructured":"Gupta N, Limbago BM, Patel JB, Kallen AJ (2011) Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 53(1):60\u201367. https:\/\/doi.org\/10.1093\/cid\/cir202","journal-title":"Clin Infect Dis"},{"key":"459_CR115","doi-asserted-by":"publisher","unstructured":"E D, A D, G S, et al. Effect of performance improvement programs on compliance with sepsis bundles and mortality: a systematic review and meta-analysis of observational studies. PloS one 2015;10(5). https:\/\/doi.org\/10.1371\/journal.pone.0125827","DOI":"10.1371\/journal.pone.0125827"},{"issue":"6","key":"459_CR116","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1128\/AAC.01509-06","volume":"51","author":"M Tumbarello","year":"2007","unstructured":"Tumbarello M, Sanguinetti M, Montuori E et al (2007) Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother 51(6):1987\u20131994. https:\/\/doi.org\/10.1128\/AAC.01509-06","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"459_CR117","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/14787210.2017.1251840","volume":"15","author":"M Bassetti","year":"2017","unstructured":"Bassetti M, Carnelutti A, Peghin M (2017) Patient specific risk stratification for antimicrobial resistance and possible treatment strategies in gram-negative bacterial infections. Expert Rev Anti Infect Ther 15(1):55\u201365. https:\/\/doi.org\/10.1080\/14787210.2017.1251840","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"11","key":"459_CR118","doi-asserted-by":"publisher","first-page":"7036","DOI":"10.1128\/AAC.01405-15","volume":"59","author":"IM Pantelidou","year":"2015","unstructured":"Pantelidou IM, Galani I, Georgitsi M, Daikos GL, Giamarellos-Bourboulis EJ (2015) Interactions of Klebsiella pneumoniae with the innate immune system vary in relation to clone and resistance phenotype. Antimicrob Agents Chemother 59(11):7036\u20137043. https:\/\/doi.org\/10.1128\/AAC.01405-15","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"459_CR119","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1365-2249.2003.02365.x","volume":"135","author":"EJ Giamarellos-Bourboulis","year":"2004","unstructured":"Giamarellos-Bourboulis EJ, Plachouras D, Tzivra A et al (2004) Stimulation of innate immunity by susceptible and multidrug-resistant Pseudomonas aeruginosa: an in vitro and in vivo study. Clin Exp Immunol 135(2):240\u2013246. https:\/\/doi.org\/10.1111\/j.1365-2249.2003.02365.x","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"459_CR120","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1093\/jac\/dkr046","volume":"66","author":"Q Lu","year":"2011","unstructured":"Lu Q, Rouby JJ, Laterre PF et al (2011) Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia. J Antimicrob Chemother 66(5):1110\u20131116. https:\/\/doi.org\/10.1093\/jac\/dkr046","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"459_CR121","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202101349","volume":"5","author":"T Cebrero-Cangueiro","year":"2022","unstructured":"Cebrero-Cangueiro T, Labrador-Herrera G, Carretero-Ledesma M et al (2022) IgM-enriched immunoglobulin improves colistin efficacy in a pneumonia model by Pseudomonas aeruginosa. Life Sci Alliance 5(10):e202101349. https:\/\/doi.org\/10.26508\/lsa.202101349","journal-title":"Life Sci Alliance"},{"issue":"2","key":"459_CR122","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s15010-014-0706-1","volume":"43","author":"FS Rossmann","year":"2015","unstructured":"Rossmann FS, Kropec A, Laverde D, Saaverda FR, Wobser D, Huebner J (2015) In vitro and in vivo activity of hyperimmune globulin preparations against multiresistant nosocomial pathogens. Infection 43(2):169\u2013175. https:\/\/doi.org\/10.1007\/s15010-014-0706-1","journal-title":"Infection"},{"issue":"1","key":"459_CR123","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/0885066616688165","volume":"34","author":"S Busani","year":"2019","unstructured":"Busani S, Serafini G, Mantovani E et al (2019) Mortality in patients with septic shock by multidrug resistant bacteria: risk factors and impact of sepsis treatments. J Intensive Care Med 34(1):48\u201354. https:\/\/doi.org\/10.1177\/0885066616688165","journal-title":"J Intensive Care Med"},{"issue":"11","key":"459_CR124","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1093\/cid\/cix646","volume":"65","author":"D Averbuch","year":"2017","unstructured":"Averbuch D, Tridello G, Hoek J et al (2017) Antimicrobial resistance in gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients: intercontinental prospective study of the infectious diseases working party of the European bone marrow transplantation group. Clin Infect Dis 65(11):1819\u20131828. https:\/\/doi.org\/10.1093\/cid\/cix646","journal-title":"Clin Infect Dis"},{"issue":"5","key":"459_CR125","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1080\/10428190902856824","volume":"50","author":"P Raanani","year":"2009","unstructured":"Raanani P, Gafter-Gvili A, Paul M, Ben-Bassat I, Leibovici L, Shpilberg O (2009) Immunoglobulin prophylaxis in chronic lymphocytic leukemia and multiple myeloma: systematic review and meta-analysis. Leuk Lymphoma 50(5):764\u2013772. https:\/\/doi.org\/10.1080\/10428190902856824","journal-title":"Leuk Lymphoma"},{"key":"459_CR126","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00507","volume":"7","author":"J Ogonek","year":"2016","unstructured":"Ogonek J, Kralj Juric M, Ghimire S et al (2016) Immune reconstitution after allogeneic hematopoietic stem cell transplantation. Front Immunol 7:507. https:\/\/doi.org\/10.3389\/fimmu.2016.00507","journal-title":"Front Immunol"},{"issue":"2","key":"459_CR127","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.blre.2017.09.003","volume":"32","author":"M Ueda","year":"2018","unstructured":"Ueda M, Berger M, Gale RP, Lazarus HM (2018) Immunoglobulin therapy in hematologic neoplasms and after hematopoietic cell transplantation. Blood Rev 32(2):106\u2013115. https:\/\/doi.org\/10.1016\/j.blre.2017.09.003","journal-title":"Blood Rev"},{"issue":"3","key":"459_CR128","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.annonc.2021.12.003","volume":"33","author":"PJ Hayden","year":"2021","unstructured":"Hayden PJ, Roddie C, Bader P et al (2021) Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA). Ann Oncol 33(3):259\u2013275. https:\/\/doi.org\/10.1016\/j.annonc.2021.12.003","journal-title":"Ann Oncol"},{"issue":"11","key":"459_CR129","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1093\/cid\/cix690","volume":"65","author":"C Girmenia","year":"2017","unstructured":"Girmenia C, Bertaina A, Piciocchi A et al (2017) Incidence, risk factors and outcome of pre-engraftment Gram-negative bacteremia after allogeneic and autologous hematopoietic stem cell transplantation: an Italian prospective multicenter survey. Clin Infect Dis 65(11):1884\u20131896. https:\/\/doi.org\/10.1093\/cid\/cix690","journal-title":"Clin Infect Dis"},{"issue":"6","key":"459_CR130","first-page":"471","volume":"17","author":"JF de Lacerda","year":"2004","unstructured":"de Lacerda JF (2004) Immunologic reconstitution after allogeneic stem cell transplant. Acta Med Port 17(6):471\u2013480","journal-title":"Acta Med Port"},{"issue":"4","key":"459_CR131","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/ejh.13580","volume":"106","author":"S Jolles","year":"2021","unstructured":"Jolles S, Michallet M, Agostini C et al (2021) Treating secondary antibody deficiency in patients with haematological malignancy: European expert consensus. Eur J Haematol 106(4):439\u2013449. https:\/\/doi.org\/10.1111\/ejh.13580","journal-title":"Eur J Haematol"},{"issue":"6","key":"459_CR132","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/s41409-022-01680-z","volume":"57","author":"A Ohmoto","year":"2022","unstructured":"Ohmoto A, Fuji S, Shultes KC, Savani BN, Einsele H (2022) Controversies about immunoglobulin replacement therapy in HSCT recipients with hypogammaglobulinemia. Bone Marrow Transplant 57(6):874\u2013880. https:\/\/doi.org\/10.1038\/s41409-022-01680-z","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"459_CR133","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.bbmt.2018.01.017","volume":"24","author":"S Bhella","year":"2018","unstructured":"Bhella S, Majhail NS, Betcher J et al (2018) Choosing Wisely BMT: American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group\u2019s List of 5 Tests and Treatments to Question in Blood and Marrow Transplantation. Biol Blood Marrow Transplant 24(5):909\u2013913. https:\/\/doi.org\/10.1016\/j.bbmt.2018.01.017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"459_CR134","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","volume":"15","author":"M Tomblyn","year":"2009","unstructured":"Tomblyn M, Chiller T, Einsele H et al (2009) Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 15(10):1143\u20131238. https:\/\/doi.org\/10.1016\/j.bbmt.2009.06.019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"459_CR135","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jaip.2024.12.024","volume":"13","author":"IM Otani","year":"2025","unstructured":"Otani IM, Ballow M (2025) If and when to consider prophylactic immunoglobulin replacement therapy in secondary hypogammaglobulinemia. J Allergy Clin Immunol Pract 13(3):511\u2013521. https:\/\/doi.org\/10.1016\/j.jaip.2024.12.024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"459_CR136","doi-asserted-by":"publisher","first-page":"103","DOI":"10.18502\/ijhoscr.v15i2.6041","volume":"15","author":"PA Fernandes","year":"2021","unstructured":"Fernandes PA, Russo FT, da Silva LAM et al (2021) The Role of IgM-Enriched Immunoglobulin (Pentaglobin) in Septic Patients with Hematological Disease. Int J Hematol Oncol Stem Cell Res 15(2):103\u2013113. https:\/\/doi.org\/10.18502\/ijhoscr.v15i2.6041","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"issue":"8","key":"459_CR137","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1080\/21645515.2019.1711298","volume":"16","author":"E Abdullayev","year":"2020","unstructured":"Abdullayev E, Kilic O, Bozan G, Kiral E, Iseri Nepesov M, Dinleyici EC (2020) Clinical, laboratory features and prognosis of children receiving IgM-enriched immunoglobulin (3 days vs. 5 days) as adjuvant treatment for serious infectious disease in pediatric intensive care unit: a retrospective single-center experience (PIGMENT study). Hum Vaccin Immunother 16(8):1997\u20132002. https:\/\/doi.org\/10.1080\/21645515.2019.1711298","journal-title":"Hum Vaccin Immunother"},{"key":"459_CR138","doi-asserted-by":"publisher","unstructured":"Alejandria MM, Lansang MAD, Dans LF, Mantaring IJB (2013) Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock. Cochrane Database Syst Rev 2018(12)\u00a0https:\/\/doi.org\/10.1002\/14651858.CD001090.pub2","DOI":"10.1002\/14651858.CD001090.pub2"},{"key":"459_CR139","doi-asserted-by":"publisher","unstructured":"Prohaska S, Schirner A, Bashota A, K\u00f6rner A, Blumenstock G, Haeberle HA. Intravenous immunoglobulin fails to improve ARDS in patients undergoing ECMO therapy. J\u00a0Intensive Care\u00a02018;6(1):11. https:\/\/doi.org\/10.1186\/s40560-018-0278-8","DOI":"10.1186\/s40560-018-0278-8"}],"container-title":["Journal of Anesthesia, Analgesia and Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s44158-026-00459-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44158-026-00459-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44158-026-00459-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:34:25Z","timestamp":1791448465000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s44158-026-00459-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,26]]},"references-count":139,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["459"],"URL":"https:\/\/doi.org\/10.1186\/s44158-026-00459-8","relation":{},"ISSN":["2731-3786"],"issn-type":[{"value":"2731-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,26]]},"assertion":[{"value":"8 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"GM is chair of the Scientific Committee of the Italian Society of Anaesthesia and Intensive Care (SIAARTI) 2025-2027 and received fees for lectures from Grifols; BS received fees for lectures from Grifols; PT received fees for lectures from BD. The remaining authors declare no conflicts of interest regarding the content of this manuscript.\u00a0EGB is the SIAARTI president.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"126"}}